======= VWA2 ======= == Gene Information == * **Official Symbol**: VWA2 * **Official Name**: von Willebrand factor A domain containing 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=340706|340706]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5GFL6|Q5GFL6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=VWA2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20VWA2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/618281|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |EGF| |VWA| |calcium-independent cell-matrix adhesion| |growth plate cartilage chondrocyte morphogenesis| |chondrocyte morphogenesis| |chondrocyte morphogenesis involved in endochondral bone morphogenesis| |growth plate cartilage morphogenesis| |growth plate cartilage chondrocyte differentiation| |chondrocyte development involved in endochondral bone morphogenesis| |cartilage morphogenesis| |chondrocyte differentiation involved in endochondral bone morphogenesis| |growth plate cartilage development| |endochondral bone growth| |chondrocyte development| |cartilage development involved in endochondral bone morphogenesis| |bone growth| |regulation of insulin receptor signaling pathway| |regulation of cellular response to insulin stimulus| |endochondral bone morphogenesis| |chondrocyte differentiation| |basement membrane| |organ growth| |bone morphogenesis| |cell-matrix adhesion| |cartilage development| |cell-substrate adhesion| |bone development| |connective tissue development| |extracellular matrix| |skeletal system morphogenesis| |protein homooligomerization| |collagen-containing extracellular matrix| |developmental growth| |growth| |skeletal system development| |protein complex oligomerization| |cell morphogenesis involved in differentiation| |tissue morphogenesis| |calcium ion binding| |cell morphogenesis| |cellular component morphogenesis| |cell adhesion| |biological adhesion| |animal organ morphogenesis| |identical protein binding| |protein-containing complex assembly| |extracellular space| |cell development| |tissue development| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|-1.96| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.71| |[[:results:exp406|Thalidomide 20μM R07 exp406]]|1.8| ^Gene^Correlation^ |[[:human genes:p:prim1|PRIM1]]|0.405| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8236 * **Expression level (log2 read counts)**: -1.95 {{:chemogenomics:nalm6 dist.png?nolink |}}